Medifuture Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.50 M
as on 16-11-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5542.61%
(FY 2023)
- Profit -0.90%
(FY 2023)
- Ebitda -16.62%
(FY 2023)
- Net Worth 28.54%
(FY 2023)
- Total Assets 6389.51%
(FY 2023)
About Medifuture Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aastha Setia and Shashi Setia serve as directors at the Company.
- CIN/LLPIN
U36103DL2009PTC190810
- Company No.
190810
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medifuture Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aastha Setia  | Director | 25-Oct-2021 | Current |
| Shashi Setia | Director | 03-Mar-2014 | Current |
Financial Performance and Corporate Structure Insights of Medifuture Pharmaceuticals.
Medifuture Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5542.61% increase. The company also saw a slight decrease in profitability, with a 0.9% decrease in profit. The company's net worth Soared by an impressive increase of 28.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medifuture Pharmaceuticals?
In 2023, Medifuture Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medifuture Pharmaceuticals?
Unlock and access historical data on people associated with Medifuture Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medifuture Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medifuture Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
